Pharmacological treatments are pivotal in ophthalmology, addressing a spectrum of conditions that affect vision. Antibiotics combat bacterial infections like conjunctivitis, while corticosteroids alleviate inflammation in conditions such as uveitis. Medications like prostaglandin analogs and beta-blockers effectively manage glaucoma by reducing intraocular pressure and averting optic nerve damage. Anti-VEGF drugs are critical in treating wet age-related macular degeneration by halting abnormal blood vessel growth.
These targeted therapies underline the tailored approach in preserving vision and enhancing patients' quality of life. In ophthalmology, each medication serves a distinct role in managing diverse eye conditions, illustrating the significance of pharmacological interventions in sustaining eye health.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom